Linden Thomas Advisory Services, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1965702 Charlotte, NC

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,184,963

+$688,822 QoQ

Shares Held

19,695

-0.2% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#151

of 462 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $9,701,809 across 5 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	54,803	$3,504,651
2	NBIX	Neurocrine Biosciences Inc	18,676	$3,147,653
3	LNTH	Lantheus Holdings, Inc. This page	19,695	$2,184,963
4	ELAN	Elanco Animal Health Inc	26,385	$649,334
5	PRGO	PERRIGO Co plc	20,713	$215,208

All Filings in LNTH

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,184,963	19,695	-0.2%	Shares	Sole	2026-07-16
2026-03-31	$1,496,141	19,725	-4.9%	Shares	Sole	2026-04-10
2025-12-31	$1,380,180	20,739	-6.4%	Shares	Sole	2026-01-16
2025-09-30	$1,136,688	22,162	0.0%	Shares	Sole	2025-11-06
2025-06-30	$1,814,181	22,162	-1.8%	Shares	Sole	2025-07-31
2025-03-31	$2,202,734	22,569	+2.9%	Shares	Sole	2025-04-30
2024-12-31	$1,962,662	21,939	-1.2%	Shares	Sole	2025-01-21
2024-09-30	$2,437,986	22,214	+0.0%	Shares	Sole	2024-10-17
2024-06-30	$1,783,000	22,207	+21.3%	Shares	Sole	2024-07-10
2024-03-31	$1,139,489	18,308	+1.0%	Shares	Sole	2024-04-30
2023-12-31	$1,124,184	18,132	-0.5%	Shares	Sole	2024-02-01
2023-09-30	$1,265,786	18,218	—	Shares	Sole	2023-10-20
No filing history on record for this holder in this stock.